Research Paper Volume 15, Issue 8 pp 2937—2969

FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma


Figure 2. Box-plots exploring the relationship between FARSB expression and clinicopathological characteristics (UALCAN). Increased FARSB expression was significantly with (A) age, (B) cancer stage, (C) tumor grade, (D) TP53 muation, (E) patient race. *P < 0.05; **P < 0.01; ***P < 0.001.